CDR-Life

CDR-Life is a biopharmaceutical company dedicated to redefining antibody therapy to help patients combat vision-threatening and life-threatening diseases, transforming their lives. The company is built on a modular antibody fragment platform for synthesizing antibodies with ideal pharmacological and drug-like properties. CDR-Life's lead program is a trispecific immunotherapy with high selectivity for tumors, offering enhanced efficacy and reduced toxicity. The company’s portfolio includes multiple first-in-class immunotherapies targeting both hematologic and solid malignancies. CDR-Life collaborates with pharmaceutical companies to bring these groundbreaking antibody therapies to patients.